Active Ingredient: AZACITIDINE
Proprietary Name: AZACITIDINE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS, SUBCUTANEOUS
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A207518
Product Number: 001
Approval Date: Sep 29, 2016
Applicant Holder Full Name: SHILPA MEDICARE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information